Data Table 3
Reportable Patients/Participation in Therapeutic Studies
Press F5 to reset the data table
Note: All values are from data submitted annually by Centers starting from 2010 to recent year.
The table below lists the high, low, median, total number of patients newly registered, and total number of patients newly enrolled on interventional therapeutic protocols at NCI-designated Clinical and Comprehensive Cancer Centers during the 12-month reporting period starting from 2010 to recent year.
| FY | Type of Center | Range | Registered Patients | Enrolled Patients | |
|---|---|---|---|---|---|
| 2015 | 17 Clinical Centers | High | 7,550 | 704 | |
| 2015 | Low | 2,065 | 114 | ||
| 2015 | Median | 3,751 | 322 | ||
| 2015 | Subtotal | 61,714 | 4,777 | ||
| 2015 | 45 Comp Centers | High | 24,429 | 6,199 | |
| 2015 | Low | 488 | 124 | ||
| 2015 | Median | 4,701 | 579 | ||
| 2015 | Subtotal | 291,371 | 41,755 | ||
| 2015 | Total | 353,085 | 46,532 | ||
| 2014 | 20 Clinical Centers | High | 5,622 | 615 | |
| 2014 | Low | 1,638 | 69 | ||
| 2014 | Median | 3,360 | 300 | ||
| 2014 | Subtotal | 47,651 | 4,121 | ||
| 2014 | 41 Comp Centers | High | 24,537 | 6,568 | |
| 2014 | Low | 0 | 162 | ||
| 2014 | Median | 4,063 | 590 | ||
| 2014 | Subtotal | 269,861 | 40,704 | ||
| 2014 | Total | 317,512 | 44,825 | ||
| 2013 | 20 Clinical Centers | High | 7,208 | 756 | |
| 2013 | Low | 1,865 | 161 | ||
| 2013 | Median | 3,426 | 305 | ||
| 2013 | Subtotal | 75,235 | 7,472 | ||
| 2013 | 41 Comp Centers | High | 23,595 | 6,675 | |
| 2013 | Low | 290 | 84 | ||
| 2013 | Median | 4,201 | 512 | ||
| 2013 | Subtotal | 224,687 | 35,425 | ||
| 2013 | Total | 299,922 | 42,897 | ||
| 2012 | 19 Clinical Centers | High | 5,469 | 732 | |
| 2012 | Low | 1,846 | 67 | ||
| 2012 | Median | 2,973 | 316 | ||
| 2012 | Subtotal | 64,510 | 7,272 | ||
| 2012 | 41 Comp Centers | High | 23,595 | 6,675 | |
| 2012 | Low | 485 | 202 | ||
| 2012 | Median | 3,825 | 535 | ||
| 2012 | Subtotal | 230,085 | 35,240 | ||
| 2012 | Total | 294,595 | 42,512 | ||
| 2011 | 19 Clinical Centers | High | 6,916 | 706 | |
| 2011 | Low | 1,842 | 122 | ||
| 2011 | Median | 3,158 | 304 | ||
| 2011 | Subtotal | 63,478 | 6,570 | ||
| 2011 | 40 Comp Centers | High | 21,996 | 7,475 | |
| 2011 | Low | 451 | 202 | ||
| 2011 | Median | 3,786 | 636 | ||
| 2011 | Subtotal | 218,696 | 42,074 | ||
| 2011 | Total | 282,174 | 48,644 | ||
| 2010 | 19 Clinical Centers | High | 6,711 | 698 | |
| 2010 | Low | 1,842 | 127 | ||
| 2010 | Median | 2,922 | 293 | ||
| 2010 | Subtotal | 61,994 | 6,818 | ||
| 2010 | 40 Comp Centers | High | 21,350 | 7,055 | |
| 2010 | Low | 457 | 235 | ||
| 2010 | Median | 3,827 | 607 | ||
| 2010 | Subtotal | 212,132 | 35,226 | ||
| 2010 | Total | 274,126 | 42,044 |
The table below lists the top 20 anatomic cancer sites for newly registered patients in the 12-month reporting period starting from 2010 to recent year at NCI-designated Clinical and Comprehensive Cancer Centers.
| FY | FY | Primary Site | Registered Patients |
|---|---|---|---|
| 2015 | Breast - Female | 48,962 | |
| 2015 | Lung | 32,900 | |
| 2015 | Prostate | 30,611 | |
| 2015 | Melanoma, Skin | 20,580 | |
| 2015 | Non-Hodgkin Lymphoma | 14,289 | |
| 2015 | Brain and Nervous System | 13,461 | |
| 2015 | Colon | 13,434 | |
| 2015 | Kidney | 13,300 | |
| 2015 | Lip, Oral Cavity and Pharynx | 13,046 | |
| 2015 | Thyroid | 12,864 | |
| 2015 | Pancreas | 11,918 | |
| 2015 | Corpus Uteri | 11,361 | |
| 2015 | Bladder | 10,664 | |
| 2015 | Liver | 9,123 | |
| 2015 | Rectum | 7,557 | |
| 2015 | Myeloid and Monocytic Leukemia | 7,521 | |
| 2015 | Multiple Myeloma | 7,010 | |
| 2015 | Soft Tissue | 6,322 | |
| 2015 | Lymphoid Leukemia | 5,882 | |
| 2015 | Ovary | 5,703 | |
| 2014 | Breast - Female | 44,130 | |
| 2014 | Lung | 28,775 | |
| 2014 | Prostate | 28,660 | |
| 2014 | Melanoma, Skin | 19,283 | |
| 2014 | Non-Hodgkin Lymphoma | 12,626 | |
| 2014 | Brain and Nervous System | 12,139 | |
| 2014 | Colon | 11,937 | |
| 2014 | Kidney | 11,707 | |
| 2014 | Thyroid | 11,640 | |
| 2014 | Lip, Oral Cavity and Pharynx | 11,598 | |
| 2014 | Pancreas | 10,432 | |
| 2014 | Corpus Uteri | 10,143 | |
| 2014 | Bladder | 9,807 | |
| 2014 | Liver | 7,948 | |
| 2014 | Myeloid and Monocytic Leukemia | 6,642 | |
| 2014 | Rectum | 6,529 | |
| 2014 | Multiple Myeloma | 6,190 | |
| 2014 | Soft Tissue | 5,775 | |
| 2014 | Lymphoid Leukemia | 5,251 | |
| 2014 | Ovary | 5,223 | |
| 2013 | Breast | 39,089 | |
| 2013 | Prostate | 29,778 | |
| 2013 | Lung | 26,477 | |
| 2013 | Melanoma, Skin | 18,552 | |
| 2013 | Non-Hodgkin Lymphoma | 12,029 | |
| 2013 | Brain and Nervous System | 11,515 | |
| 2013 | Lip, Oral Cavity and Pharynx | 11,475 | |
| 2013 | Colon | 11,344 | |
| 2013 | Kidney | 10,845 | |
| 2013 | Thyroid | 10,120 | |
| 2013 | Pancreas | 9,771 | |
| 2013 | Corpus Uteri | 9,221 | |
| 2013 | Bladder | 8,805 | |
| 2013 | Liver | 7,222 | |
| 2013 | Myeloid and Monocytic Leukemia | 6,046 | |
| 2013 | Rectum | 6,014 | |
| 2013 | Multiple Myeloma | 5,551 | |
| 2013 | Soft Tissue | 5,389 | |
| 2013 | Lymphoid Leukemia | 4,946 | |
| 2013 | Ovary | 4,877 | |
| 2012 | Breast – Female | 38,473 | |
| 2012 | Prostate | 31,414 | |
| 2012 | Lung | 26,168 | |
| 2012 | Melanoma, Skin | 17,587 | |
| 2012 | Non-Hodgkin Lymphoma | 11,875 | |
| 2012 | Brain and Nervous System | 11,786 | |
| 2012 | Colon | 11,409 | |
| 2012 | Lip, Oral Cavity and Pharynx | 10,762 | |
| 2012 | Kidney | 10,505 | |
| 2012 | Thyroid | 9,385 | |
| 2012 | Pancreas | 9,130 | |
| 2012 | Corpus Uteri | 8,977 | |
| 2012 | Bladder | 8,371 | |
| 2012 | Liver | 6,809 | |
| 2012 | Rectum | 6,189 | |
| 2012 | Myeloid and Monocytic Leukemia | 6,016 | |
| 2012 | Soft Tissue | 5,493 | |
| 2012 | Multiple Myeloma | 5,356 | |
| 2012 | Ovary | 5,123 | |
| 2012 | Lymphoid Leukemia | 4,976 | |
| 2011 | Breast - Female | 35,881 | |
| 2011 | Prostate | 28,817 | |
| 2011 | Lung | 24,386 | |
| 2011 | Melanoma, skin | 15,129 | |
| 2011 | Brain and Nervous System | 10,724 | |
| 2011 | Non-Hodgkin's Lymphoma | 10,620 | |
| 2011 | Colon | 10,584 | |
| 2011 | KIDNEY | 9,428 | |
| 2011 | Thyroid | 8,713 | |
| 2011 | Pancreas | 8,086 | |
| 2011 | Lip, Oral Cavity and Pharynx | 7,859 | |
| 2011 | Corpus Uteri | 6,252 | |
| 2011 | Urinary Bladder | 6,086 | |
| 2011 | Rectum | 5,500 | |
| 2011 | Liver | 5,490 | |
| 2011 | Soft Tissue | 4,990 | |
| 2011 | Myeloid and Monocytic Leukemia | 4,751 | |
| 2011 | Multiple Myeloma | 4,435 | |
| 2011 | Ovary | 4,429 | |
| 2011 | Stomach | 3,989 | |
| 2010 | Breast - Female | 36,367 | |
| 2010 | Prostate | 31,239 | |
| 2010 | Lung | 24,642 | |
| 2010 | Melanoma, skin | 15,857 | |
| 2010 | Brain and Nervous System | 11,074 | |
| 2010 | Colon | 10,975 | |
| 2010 | Non-Hodgkin’s Lymphoma | 10,459 | |
| 2010 | Lip, Oral Cavity and Pharynx | 9,577 | |
| 2010 | Kidney | 9,527 | |
| 2010 | Pancreas | 8,752 | |
| 2010 | Corpus Uteri | 8,258 | |
| 2010 | Thyroid | 8,227 | |
| 2010 | Bladder | 7,583 | |
| 2010 | Liver | 5,700 | |
| 2010 | Rectum | 5,456 | |
| 2010 | Soft Tissue | 5,238 | |
| 2010 | Myeloid and Monocytic Leukemia | 5,200 | |
| 2010 | Ovary | 4,853 | |
| 2010 | Lymphoid Leukemia | 4,379 | |
| 2010 | Esophagus | 4,027 |
The table below lists the top 20 anatomic cancer sites for newly enrolled patients in the 12-month reporting period starting from 2010 to recent year at NCI-designated Clinical and Comprehensive Cancer Centerss.
| FY | Primary Site | Enrolled Patients | |
|---|---|---|---|
| 2015 | Breast - Female | 6,048 | |
| 2015 | Lung | 4,092 | |
| 2015 | Prostate | 3,455 | |
| 2015 | Myeloid and Monocytic Leukemia | 3,424 | |
| 2015 | Lymphoid Leukemia | 2,466 | |
| 2015 | Brain and Nervous System | 2,298 | |
| 2015 | Non-Hodgkin Lymphoma | 2,263 | |
| 2015 | Melanoma, Skin | 2,078 | |
| 2015 | Multiple Myeloma | 2,050 | |
| 2015 | Colon | 1,661 | |
| 2015 | Pancreas | 1,579 | |
| 2015 | Other Hematopoietic | 1,506 | |
| 2015 | Kidney | 1,409 | |
| 2015 | Lip, Oral Cavity and Pharynx | 1,364 | |
| 2015 | Ovary | 1,364 | |
| 2015 | Soft Tissue | 1,071 | |
| 2015 | Liver | 986 | |
| 2015 | Bladder | 776 | |
| 2015 | Hodgkin Lymphoma | 674 | |
| 2015 | Corpus Uteri | 535 | |
| 2014 | Breast - Female | 5,961 | |
| 2014 | Lung | 3,816 | |
| 2014 | Prostate | 3,353 | |
| 2014 | Myeloid and Monocytic Leukemia | 3,272 | |
| 2014 | Lymphoid Leukemia | 2,588 | |
| 2014 | Brain and Nervous System | 2,357 | |
| 2014 | Non-Hodgkin Lymphoma | 2,126 | |
| 2014 | Melanoma, Skin | 2,104 | |
| 2014 | Multiple Myeloma | 1,919 | |
| 2014 | Colon | 1,460 | |
| 2014 | Ovary | 1,456 | |
| 2014 | Pancreas | 1,400 | |
| 2014 | Kidney | 1,321 | |
| 2014 | Other Hematopoietic | 1,292 | |
| 2014 | Lip, Oral Cavity and Pharynx | 1,266 | |
| 2014 | Soft Tissue | 1,184 | |
| 2014 | Liver | 897 | |
| 2014 | Bladder | 657 | |
| 2014 | Leukemia, other | 571 | |
| 2014 | Unknown Sites | 542 | |
| 2013 | Breast | 5,456 | |
| 2013 | Lung | 3,440 | |
| 2013 | Prostate | 3,430 | |
| 2013 | Myeloid and Monocytic Leukemia | 2,902 | |
| 2013 | Lymphoid Leukemia | 2,351 | |
| 2013 | Brain and Nervous System | 2,108 | |
| 2013 | Non-Hodgkin Lymphoma | 2,018 | |
| 2013 | Melanoma, Skin | 1,752 | |
| 2013 | Pancreas | 1,698 | |
| 2013 | Multiple Myeloma | 1,574 | |
| 2013 | Colon | 1,524 | |
| 2013 | Ovary | 1,301 | |
| 2013 | Kidney | 1,159 | |
| 2013 | Other Hematopoietic | 1,154 | |
| 2013 | Lip, Oral Cavity and Pharynx | 1,150 | |
| 2013 | Soft Tissue | 1,017 | |
| 2013 | Liver | 1,014 | |
| 2013 | Bladder | 706 | |
| 2013 | Hodgkin Lymphoma | 638 | |
| 2013 | Corpus Uteri | 634 | |
| 2012 | Breast – Female | 5,697 | |
| 2012 | Prostate | 3,629 | |
| 2012 | Lung | 3,605 | |
| 2012 | Myeloid and Monocytic Leukemia | 2,682 | |
| 2012 | Brain and Nervous System | 2,380 | |
| 2012 | Melanoma, Skin | 2,295 | |
| 2012 | Lymphoid Leukemia | 2,097 | |
| 2012 | Non-Hodgkin Lymphoma | 1,841 | |
| 2012 | Multiple Myeloma | 1,667 | |
| 2012 | Colon | 1,550 | |
| 2012 | Pancreas | 1,432 | |
| 2012 | Other Hematopoietic | 1,210 | |
| 2012 | Ovary | 1,205 | |
| 2012 | Lip, Oral Cavity and Pharynx | 1,142 | |
| 2012 | Soft Tissue | 1,005 | |
| 2012 | Kidney | 953 | |
| 2012 | Liver | 924 | |
| 2012 | Hodgkin Lymphoma | 678 | |
| 2012 | Rectum | 598 | |
| 2012 | Corpus Uteri | 572 | |
| 2011 | Breast - Female | 6,214 | |
| 2011 | Lung | 3,967 | |
| 2011 | Prostate | 3,119 | |
| 2011 | Myeloid and Monocytic Leukemia | 2,453 | |
| 2011 | Brain and Nervous System | 2,294 | |
| 2011 | Melanoma, skin | 2,290 | |
| 2011 | Non-Hodgkin's Lymphoma | 1,841 | |
| 2011 | Lymphoid Leukemia | 1,811 | |
| 2011 | Colon | 1,474 | |
| 2011 | Pancreas | 1,348 | |
| 2011 | Multiple Myeloma | 1,303 | |
| 2011 | Ovary | 1,283 | |
| 2011 | Lip, Oral Cavity and Pharynx | 1,220 | |
| 2011 | Other Hematopoietic | 1,158 | |
| 2011 | KIDNEY | 1,049 | |
| 2011 | Soft Tissue | 985 | |
| 2011 | Liver | 721 | |
| 2011 | Urinary Bladder | 552 | |
| 2011 | Rectum | 530 | |
| 2011 | Bones and Joints | 470 | |
| 2010 | Breast - Female | 6,728 | |
| 2010 | Lung | 3,488 | |
| 2010 | Prostate | 3,067 | |
| 2010 | Myeloid and Monocytic Leukemia | 2,852 | |
| 2010 | Brain and Nervous System | 2,220 | |
| 2010 | Melanoma, skin | 2,061 | |
| 2010 | Non-Hodgkin’s Lymphoma | 2,053 | |
| 2010 | Lymphoid Leukemia | 1,906 | |
| 2010 | Multiple Myeloma | 1,491 | |
| 2010 | Colon | 1,408 | |
| 2010 | Ovary | 1,259 | |
| 2010 | Pancreas | 1,251 | |
| 2010 | Kidney | 1,123 | |
| 2010 | Soft Tissue | 1,072 | |
| 2010 | Lip, Oral Cavity and Pharynx | 990 | |
| 2010 | Other Hematopoietic | 981 | |
| 2010 | Hodgkin’s Lymphoma | 633 | |
| 2010 | Bladder | 569 | |
| 2010 | Liver | 549 | |
| 2010 | Bones and Joints | 546 |